Median survival time and survival rate in the treatment groups
| Group | FaDu xenograft mice | SCC40 xenograft mice | ||||
|---|---|---|---|---|---|---|
| n | Survival rate (%) | Median survival time (95% CI), d | n | Survival rate (%) | Median survival time (95% CI), d | |
| Control | 5 | 0.0 | 19 (15-28) | 6 | 0.0 | 27 (20-34) |
| Cisplatin | 5 | 20.0 | 23 (13-∞) | 5 | 0.0 | 22 (16-46) |
| CCI-779 | 6 | 0.0 | 35 (28-40) | 5 | 40.0 | 52 (34-∞) |
| Cisplatin + CCI-779 | 6 | 16.7 | 28 (28-37) | 6 | 40.0 | 55 (39-∞) |
| XRT | 6 | 0.0 | 37 (33-40) | 6 | 16.7 | 35 (34-39) |
| Cisplatin + XRT | 6 | 33.3 | 47.5 (26-∞) | 6 | 0.0 | 38 (36-43) |
| CCI-779 + XRT | 6 | 66.7 | >56 (56-∞) | 6 | 16.7 | 49 (46-57) |
| Cisplatin + CCI-779 + XRT | 6 | 16.7 | 52 (42-58) | 6 | 66.7 | >50 (50-∞) |